Alzheimer's Disease Research News

Research breakthrough gives hope to those suffering from a genetic form of macular degeneration known as Stargardt disease.

BrightFocus Foundation’s 2023 annual report highlights an incredible year of pioneering neurodegenerative research.  

In this issue: President’s Corner, Obesity and Macular Degeneration: What's the Link? New FDA-Approved Treatments for Geographic Atrophy, and more!

BrightFocus Foundation’s second Macular Fast Track program will train promising graduate students, postdoctoral fellows, and other early-career scientists to help speed progress toward a cure for macular degeneration.

BrightFocus Foundation reaffirms its commitment to funding breakthrough research for macular degeneration and glaucoma and providing valuable resources for people living with low vision.

BrightFocus-funded research has shed new light on a way to block a “master switch” in the microglia, introducing a possible target for combatting glaucoma as well as other neurodegenerative diseases.